Life Biosciences

Stub active Updated Apr 12, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Boston, Massachusetts
Founded 2017
Latest Stage Series D
Total Raised $80M+
Website https://www.lifebiosciences.com
Sector
biotech longevity therapeutics

Founders

David Sinclair Co-Founder

About

Life Biosciences is a Boston-based biotechnology company developing cellular rejuvenation therapies using its proprietary Partial Epigenetic Reprogramming (PER) platform 1. The company’s lead program ER-100 is in Phase 1 clinical trials for optic neuropathies including glaucoma and NAION 12.

Funding History

Date Round Amount Lead Co-investors
2026-04-08 Series D $80M Undisclosed 12

What Investors Say

No verified investor quotes available at this time.

What Founders Say

No verified founder quotes available at this time.

Sources

  1. GlobeNewsWire, “Life Biosciences Secures $80 Million Series D Financing,” April 8, 2026. https://www.globenewswire.com/news-release/2026/04/08/3270043/0/en/Life-Biosciences-Secures-80-Million-Series-D-Financing.html↩↩↩

  2. FinSMEs, “Life Biosciences Raises $80M in Series D Funding,” April 2026. https://www.finsmes.com/2026/04/life-biosciences-raises-80m-in-series-d-funding.html↩↩